ArticleNeuro-oncology advances

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma.

Bronwen E Foreman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.